Aayush Wellness has announced the launch of its Lung Care Tablets, marking a significant expansion of its prevention-led healthcare vision. According to reports from Business Standard, the company is building on the proposition of Aayush Herbal Masala, which was developed around health concerns associated with smokeless-tobacco consumption. The new product extends the company's focus to respiratory wellness, addressing growing health challenges associated with smoking, air pollution and environmental exposure.
The launch comes at a time when India's respiratory healthcare segment represents a significant and growing market opportunity. As reported by Business Standard, the Respiratory System therapeutic segment recorded sales of ₹18,912.64 crore in 2025, up from ₹17,199.40 crore in 2024, representing approximately 10% YoY growth. With India accounting for 30.28% of global deaths from respiratory diseases, Aayush Wellness sees an opportunity to build a differentiated position in the emerging preventive respiratory-wellness category.
The company's expansion into respiratory wellness represents a strategic shift from its traditional focus on smokeless-tobacco health concerns to broader respiratory health solutions. According to Business Standard, this move positions Aayush Wellness to capitalize on the growing awareness and demand for preventive healthcare products in India's evolving healthcare landscape.
